Skip to Main Content

Paper Details

FRAMe: Familial Risk Assessment of Melanoma-a risk prediction tool to guide CDKN2A germline mutation testing in Australian familial melanoma.
Fam Cancer
4
2021
CDKN2A, CDKN2A mutation, Melanoma, cancer, cutaneous melanoma, familial melanoma, melanoma, non-melanoma skin cancer, pancreatic cancer
Author NameAffiliation
Nicholas K HaywardQIMR Berghofer Medical Research Institute
Nicholas K HaywardQIMR Berghofer Medical Research Institute
  • 1 - 2

Datasets

Release 1.2